Leadership Announcement

[Anonymous]

Crazy, crazy. And there's no chance he's going to Supernus.

 

[Anonymous]

Angus is abandoning ship! He knows the writing is on the wall and knows the decision to buy ABH was a major mistake. The justice department is uncovering things that will cost this company big money in fines while they also uncovered the accounting fraud that KOB perpetuated. He was running a ponzi scheme that inflated the value of ABH and made him and his cronies millionaires. Don't spend it too fast KOB this is not over. You'll look good in an orange jumpsuit! Oh and as for Angus, great job with your due diligence before buying this POS company!

 

[Anonymous]

Reps are leaving RM. in droves. Theses geniuses brought in managers from Shire that know zero about wound care to manage this business . They reduced total comp by about 30% and used ZS associates to carve up territories that make no sense at all. Most of the federal reps have moved on to sell a new product that is killing Dermagraft in the VA's When will we stop making stupid decisions and get people in here that know what they are doing. This company is going down the crapper faster than Angus can cash out his stock options. Abandon ship people, abandon ship!

 

[Anonymous]

Re: Shire down the tubes Globally

Yeah, well forget US, Globally Shire is going down the tubes. They expanded alot in a short period of time without thinking about Profitablity in the Long Term.

In the European countries, there are layoffs and the forcasts are not meeting expectations. They think ADHD will save the company but it won't. Kids just don't have ADHD in Europe and the amount of potential sales (market size and access) is over-estimated. Not only that they want to launch Vyvance in a market with generics, with questionable data.

All the other companies have pulled out of the ADHD space. And the other products are not that great. The one product Fosrenol, they could have milked that more, before pulling the plug.

What makes matters worse, is that in Global hubs (UK/Switzerland) they think they are a big-pharma. They put all these policies in place that restrict the conduct of business. They can't even get promotional material out in time. So makes sense Angus is gone.

All the idiots that put this boat together have abandoned ship (got fired like JS, or gone).

So await your severance package, and sell your stock. This puppy is heading down..and forget about stimulants in other CNS areas. Will never sell.

I have my interviews lined up...you should all do the same. Cheers mates

 

[Anonymous]

Re: Shire down the tubes Globally

Yeah, well forget US, Globally Shire is going down the tubes. They expanded alot in a short period of time without thinking about Profitablity in the Long Term.

In the European countries, there are layoffs and the forcasts are not meeting expectations. They think ADHD will save the company but it won't. Kids just don't have ADHD in Europe and the amount of potential sales (market size and access) is over-estimated. Not only that they want to launch Vyvance in a market with generics, with questionable data.

All the other companies have pulled out of the ADHD space. And the other products are not that great. The one product Fosrenol, they could have milked that more, before pulling the plug.

What makes matters worse, is that in Global hubs (UK/Switzerland) they think they are a big-pharma. They put all these policies in place that restrict the conduct of business. They can't even get promotional material out in time. So makes sense Angus is gone.

All the idiots that put this boat together have abandoned ship (got fired like JS, or gone).

So await your severance package, and sell your stock. This puppy is heading down..and forget about stimulants in other CNS areas. Will never sell.

I have my interviews lined up...you should all do the same. Cheers mates

Not idiots.. For some reason Gary still has a job

 

[Anonymous]

Re: Shire down the tubes Globally

Yeah, well forget US, Globally Shire is going down the tubes. They expanded alot in a short period of time without thinking about Profitablity in the Long Term.

In the European countries, there are layoffs and the forcasts are not meeting expectations. They think ADHD will save the company but it won't. Kids just don't have ADHD in Europe and the amount of potential sales (market size and access) is over-estimated. Not only that they want to launch Vyvance in a market with generics, with questionable data.

All the other companies have pulled out of the ADHD space. And the other products are not that great. The one product Fosrenol, they could have milked that more, before pulling the plug.

What makes matters worse, is that in Global hubs (UK/Switzerland) they think they are a big-pharma. They put all these policies in place that restrict the conduct of business. They can't even get promotional material out in time. So makes sense Angus is gone.

All the idiots that put this boat together have abandoned ship (got fired like JS, or gone).

So await your severance package, and sell your stock. This puppy is heading down..and forget about stimulants in other CNS areas. Will never sell.

I have my interviews lined up...you should all do the same. Cheers mates

Adsett fucked up with Resolor